Experienced Leadership

Helix is led by experienced Management and Board team with excellent pharmaceutical development expertise and proven business skills. The group is committed in developing novel medicines through DOS47 and cell-based platforms.

MANAGEMENT BOARD

Heman Chao

CEO
PhD

Biochemist with expertise in protein drug development. Previous role with Sensium Technologies Inc.

Frank Michalargias

CFO
CPA, CA

Public company CFO with broad industry experience including senior positions with Unilever and Huhtamaki Oy

Paweł Wiśniewski

CEO Poland
PhD

Biochemistry background;  co-founder Institute of Genetic Analysis

BOARD OF DIRECTORS

Sławomir Majewski

MD, PhD

Vice Rector of the Medical University of Warsaw, Corresponding Member of the Polish Academy of Science

Marek Orłowski

MD

Chairman/Founder Adiuvo Investments, Founder Nepentes, sold to Sanofi Aventis

Sylwester Cacek

Founder of Dominet Bank which was sold to Fortis Bank Group; President/founder of Sfinks Polska

Heman Chao

PhD

Biochemist with expertise in protein drug development. Previous role with Sensium Technologies Inc.